Founded in 2016, Genechron offers advanced genomics analysis services for diagnostic purposes, transfer of human therapies from pre-clinical to clinical fields, nutrigenetic analysis, and veterinary applications. The company has highly specialized personnel who have been working in the field of molecular biology and genetics for over 10 years, and collaborates with research centers on various projects. Genechron has received capital risk financing through the POR I.3 Venture Capital Fund of the Lazio Region via Lazio Innova Spa. The clinic department is staffed with physicians including gynecologists, nutritionists, biologists, and geneticists, and uses modern and advanced technologies.